Figures & data
Table 1 Characteristics of Included RCTs
Figure 2 The risk of bias of the included studies; (a) risk of bias for each study; (b) risk of bias summary.
![Figure 2 The risk of bias of the included studies; (a) risk of bias for each study; (b) risk of bias summary.](/cms/asset/14de6e1c-66df-4393-a691-e50688deb9e9/djpr_a_12300223_f0002_c.jpg)
Figure 3 The incidence of propofol injection pain in the ketamine group compared with the saline group.
![Figure 3 The incidence of propofol injection pain in the ketamine group compared with the saline group.](/cms/asset/416d99dd-40f7-4412-a6d0-8b24672e9363/djpr_a_12300223_f0003_c.jpg)
Figure 4 The incidence of propofol injection pain in the ketamine group compared with the lidocaine group.
![Figure 4 The incidence of propofol injection pain in the ketamine group compared with the lidocaine group.](/cms/asset/d9e5d105-607d-4df3-a225-e001da48f27a/djpr_a_12300223_f0004_c.jpg)
Figure 5 The incidence of propofol injection pain in the ketamine group compared with the dexmedetomidine group.
![Figure 5 The incidence of propofol injection pain in the ketamine group compared with the dexmedetomidine group.](/cms/asset/7887c039-99dd-4abc-9be5-a879420a5ce2/djpr_a_12300223_f0005_c.jpg)
Figure 6 The incidence of propofol injection pain in the ketamine group compared with the thiopental group.
![Figure 6 The incidence of propofol injection pain in the ketamine group compared with the thiopental group.](/cms/asset/ec71a10f-ced7-400e-a6cd-0e7f5718c9c4/djpr_a_12300223_f0006_c.jpg)
Figure 7 The incidence of propofol injection pain in the separate injection group compared with the mixed injection group.
![Figure 7 The incidence of propofol injection pain in the separate injection group compared with the mixed injection group.](/cms/asset/067850a5-d66d-4f78-bdf0-70abe54a113b/djpr_a_12300223_f0007_c.jpg)
Figure 8 The incidence of severe propofol injection pain in the ketamine group compared with the saline group.
![Figure 8 The incidence of severe propofol injection pain in the ketamine group compared with the saline group.](/cms/asset/f9ecc7a4-3112-4179-9917-4ba719190298/djpr_a_12300223_f0008_c.jpg)
Figure 9 The incidence of severe propofol injection pain in the ketamine group compared with the lidocaine group.
![Figure 9 The incidence of severe propofol injection pain in the ketamine group compared with the lidocaine group.](/cms/asset/565f9ae5-9e9b-4a4f-839e-1afba2f3c397/djpr_a_12300223_f0009_c.jpg)
Figure 10 The incidence of severe propofol injection pain in the ketamine group compared with the dexmedetomidine group.
![Figure 10 The incidence of severe propofol injection pain in the ketamine group compared with the dexmedetomidine group.](/cms/asset/43d47bad-26cb-4fa8-b001-8962b0476036/djpr_a_12300223_f0010_c.jpg)
Figure 11 The incidence of severe propofol injection pain in the ketamine group compared with the thiopental group.
![Figure 11 The incidence of severe propofol injection pain in the ketamine group compared with the thiopental group.](/cms/asset/080db86b-e3e4-43bb-8ab8-ac673abc0137/djpr_a_12300223_f0011_c.jpg)
Figure 12 The incidence of severe propofol injection pain in the separate injection group compared with the mixed injection group.
![Figure 12 The incidence of severe propofol injection pain in the separate injection group compared with the mixed injection group.](/cms/asset/b228f317-1ad4-4744-a0ff-f3c85be5e4ba/djpr_a_12300223_f0012_c.jpg)
Figure 13 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the saline group.
![Figure 13 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the saline group.](/cms/asset/10a39da3-77d4-4e97-ad51-6be08b52ee1f/djpr_a_12300223_f0013_c.jpg)
Figure 14 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the lidocaine group.
![Figure 14 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the lidocaine group.](/cms/asset/9c738f50-cec9-4e02-aefa-7248b4993a47/djpr_a_12300223_f0014_c.jpg)
Table 2 Results of Egger Tests and Trim-and-Fill Procedure